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Abstract
Background: High incidences of silent cerebral ischemia (SCI) have been revealed by diffusion-weight-
ed magnetic resonance imaging (DW MRI) after pulmonary vein isolation (PVI) for atrial fibrillation. 
A high number of mostly gaseous micro-embolic signals (MESs) was detected by transcranial Doppler 
(TCD) during PVI. In this investigation the possible relationship between MESs detected intraopera-
tively by TCD and new SCI on DW MRI post-ablation is reported.
Methods: 27 consecutive atrial fibrillation patients (6 female, age median: 64 interquartile range: 13.23) 
undergoing PVI with the pulmonary vein ablation catheter, pre- and post-ablation DW MRI and intra-
operative MES detection by TCD were included in the study. Procedures were performed on a therapeutic 
international normalized ratio (2–3) and with a target activated clotting time ≥ 350 s in all patients. DW 
MRI scans performed pre- and post-ablation revealed new SCI in 6 out of 27 (22%) patients.
Results: The median (interquartile range) MES count recorded during the whole procedure was 1642 
(912) in patients with and 1019 (529) in those without SCI (p = 0.129). The number of MESs recorded 
during pulmonary vein angiography was significantly higher in patients as compared to those without 
a new lesion on the post-ablation DW MRI: 257 (249) vs. 110 (71), respectively (p = 0.0009). On mul-
tivariate logistic regression, the total MES count was predictive of SCI in patients older than 68 years.
Conclusions: Micro-embolus generation detected by TCD during pulmonary vein angiography signifi-
cantly correlates with new SCI on DW MRI post-ablation. (Cardiol J 2017; 24, 3: 234–241)
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Introduction
Silent cerebral ischemia (SCI) observed on 
diffusion-weighted magnetic resonance imaging 
(DW MRI) as a complication of atrial fibrillation 
(AF) ablation has been reported at varying rates 
[1–7] and generated significant concern regarding 
the long-term consequences of these procedures. 
The diagnosis of SCI is based on the comparison 
of two cerebral DWI MRI examinations, usually 
performed 48–72 h apart with the AF ablation 
procedure carried out between them. This imaging 
modality provides no intra-procedural data which 
would suggest the mechanism of lesion forma-
tion. In contrast, bilateral insonation of the middle 
cerebral artery (MCA) using transcranial Doppler 
(TCD) offers a real-time assessment of micro- 
-embolization throughout the whole procedure. 
The use of TCD during AF ablation was first report-
ed by Kilicaslan et al. [8], who found a significant 
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relationship between the number of micro-embolic 
signals (MESs) on TCD and clinical stroke events. 
The present group has demonstrated that the ma-
jority of MESs are gaseous and the generation of 
micro-emboli is concentrated in the phase of energy 
delivery with some ablation techniques [9, 10]. 
Further, the site of ablation, the ongoing rhythm 
and certain biophysical parameters during phased 
radiofrequency (RF) ablation have been found to be 
predictive of the rate of microembolization [11, 12].
This was prospectively investigated and the 
rate of micro-embolization during pulmonary vein 
isolation (PVI) and the incidence of new post-
ablation cerebral lesions on DW MRI in patients 
undergoing PVI with phased RF and the pulmonary 
vein ablation catheter (PVAC) was reported.
Methods
Study population
Consecutive patients undergoing PVI with 
the PVAC and the GENius TM 14.4 RF generator 
for symptomatic paroxysmal or persistent, but 
not long-standing persistent AF not adequately 
controlled by at least one antiarrhythmic drug 
were considered for enrollment in the study. All 
these patients were asked to consent to continu-
ous, bilateral TCD detection during the ablation 
procedure, and to DW MRI examinations before 
and after PVI. Standard exclusion criteria includ-
ing hyper- or hypothyroidism, heart failure, left 
atrial (LA) diameter exceeding 50 mm and previ-
ous clinical ischemic stroke or transient ischemic 
attack were applied. The study design conformed 
with the guiding principles of the Declaration of 
Helsinki, and was approved by the Institutional 
Ethics Committee. 
Ablation procedure
Patients were hospitalized 1 or 2 days before 
the procedure. Transesophageal echocardiography 
was carried out within 24 h prior to the procedure 
in order to rule out the presence of a cardiac 
thrombus. All procedures were performed on un-
interrupted vitamin K antagonist therapy with 
a target international normalized ratio of 2.0 to 3.0, 
which was confirmed on the day of the ablation. 
The ablation protocol was reported earlier [10–12]. 
In brief, under conscious sedation, decapolar and 
quadripolar catheters were advanced from the 
femoral vein and positioned in the coronary sinus 
and the right ventricle. Immediately before trans-
septal puncture, a 150 IU/kg body weight i.v. 
heparin bolus was given, followed by a continuous 
infusion and additional 2000–5000 IV i.v. boluses 
of heparin were administered if needed to reach 
a target activated clotting time (ACT) level of 350 s. 
The ACT was always checked prior to the first abla-
tion and every 20 min thereafter. RF delivery was 
not started until the ACT reached at least 300 s. 
A single trans-septal puncture was performed under 
fluoroscopic and intra-cardiac echocardiographic 
guidance, using a standard technique and an 8.5 F 
SL0 Swartz sheath (St Jude Medical, Minnetonka, 
MN, USA). This sheath was then exchanged for 
a deflectable 65-cm-long sheath with a 12-Fr in-
ner lumen (FlexCath, Medtronic CryoCath LP, 
Kirkland, Quebec, Canada) to be used as a guide 
for the PVAC (Ablation Frontiers, Medtronic, 
Carlsbad, CA, USA). The distal circular segment 
of the PVAC was captured under saline before 
introduction into the sheath in order to eliminate 
any microbubbles possibly entrapped between the 
electrode arrays.
The PVAC was positioned consecutively at 
the ostia of each pulmonary vein (PV). The proper 
position was assessed before the first RF deliv-
ery at each PV by means of a hand-held injection 
(8–10 mL) of contrast medium (Optiray, Covidien 
Deutschland GmbH, Germany) diluted with saline 
in a 1:1 ratio through the FlexCath sheath, which 
was positioned close to the anticipated PV ostium. 
The saline infusion used for continuous flushing 
of the FlexCath sheath was interrupted for PV 
angiography and meticulous care was taken to 
eliminate any air bubbles in the sheath and in the 
syringe before contrast injections.
Once the optimal catheter position has been 
confirmed RF energy was applied in a 2:1 bipolar/ 
/unipolar mode for 60 s, usually 3–4 times per PV. 
Simultaneous RF energy delivery to PVAC elec-
trodes 1 (E1) and 10 (E10) was initiated only after 
careful fluoroscopic assessment of their positions 
when the inter-electrode distance appeared at 
least twice the fixed distance between two other 
adjacent electrodes. The electrode position was 
checked periodically during RF delivery. Any elec-
trode pair that failed to reach a minimum of 50oC 
during RF delivery was switched off. RF delivery 
was also discontinued to electrodes after having 
reached the target temperature while delivering 
very low power (1–2 W).
The procedural endpoint was electrical isola-
tion of all PVs, as confirmed by an entrance block 
evidenced by the disappearance of PV potentials 
is sinus rhythm, during coronary sinus pacing 
or during AF. No electrical cardioversion had 
been performed during the procedure or in the 
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earlypost-ablation period before repeat cerebral 
MRI was completed. Heparin was discontinued 
at the end of the procedure with no protamine ad-
ministered and the venous sheaths were removed 
4–6 h later.
TCD recording and evaluation
Transcranial Doppler recording was performed 
throughout the whole period of LA access. The 
transducer was held in place by a proprietary head-
piece supplied with the system. The MCAs were 
bilaterally insonated from trans-temporal windows 
by using a multi-frequency Doppler (Multi Dop 
T digital, DWL, QL software 2.8) which insonates 
simultaneously with frequencies of 2 MHz and 
2.5 MHz. The system is capable of the automatic 
online identification of true MESs with a sensitiv-
ity of 100% and a specificity of 99.3% and it also 
distinguishes between gaseous and solid emboli 
with a specificity of 96.5% [13, 14]. TCD parameter 
settings were as recommended by the consensus 
criteria [15] and were kept constant during the 
procedures. The insonation depth was 45–55 mm, 
the sample volume was 8 mm, and the power was 
60–100 mW. MES counts were collected and evalu-
ated separately during the different stages of the 
procedure as follows:
 — trans-septal puncture: the 30-s period after 
crossing the interatrial septum with the trans-
septal needle;
 — PV angiography: contrast injection through 
the FlexCath trans-septal sheath. MESs were 
counted until they gradually decreased and 
disappeared after a marked burst, which usu-
ally followed the bolus within 5–10 s;
 — energy delivery: from the start until 15 s after 
termination of energy delivery;
 — the remainder of the procedure: that part of 
LA access period during which none of the 
aforementioned maneuvers were performed.
As bilateral recording was technically not pos-
sible in all patients, MES counts were calculated 
as mean MES count per patient, using either the 
mean of the bilateral counts when both sides were 
measured, or the unilateral data when only one 
side was available.
Cerebral MRI
Cerebral MRI was performed the day before 
and within 48 h after the procedure using a GE 
Sigma Excite 1.5 T (GE Medical Systems, Milwau-
kee, USA) scanner and an 8-channel phased array 
head coil. A routine brain imaging protocol was 
performed, including anaxial diffusion-weighted 
(DWI) single-shot spin echo, echo-planar sequence 
[diffusion gradient b-values of 0 and 1000 s/mm2, 
repetition time (TR): 8700 ms, echo time (TE): 104 
ms, slice thickness: 5 mm, matrix: 128 × 128], an 
axial T2-weighted fast spin echo (TR: 5640 ms, TE: 
95 ms, slice thickness: 3 mm, matrix: 320 × 256), 
a sagittal T1-weighted spin echo (TR: 480 ms, TE: 
12 ms, slice thickness: 3 mm, matrix: 256 × 160) 
and a coronal fluid attenuated inversion recovery 
(FLAIR) [TR: 8002 ms, TE: 130 ms, slice thick-
ness: 4 mm, matrix: 320 × 160] sequence. In addi-
tion, a 25 directions DWI sequence was performed 
for advanced diffusion mapping.
DW MRI data were analyzed by two radiol-
ogy experts blinded to the clinical status of the 
patients. The pre-procedure MRI was compared 
with the post-procedure MRI to identify any new 
procedure-related acute cerebral lesion defined 
as a focal hyper-intense area detected on the DWI 
confirmed by apparent diffusion coefficient map-
ping to rule out a shine-through artifact. The size 
and localization of focal diffusion abnormalities 
were analyzed. For patients who were positive 
for a new DWI lesion in the post-procedure MRI, 
another follow-up MRI was performed 3-month 
post-ablation.
Statistical analysis
Complete data sets for all patients were col-
lected, including the results of intra-procedural 
TCD monitoring, pre- and post-ablation DW MRI. 
Patient and procedural characteristics were evalu-
ated by using means and standard deviation (SD) 
or medians and interquartile range (IQR) for 
continuous variables accordingly, and counts and 
percentages for categorical variables. Groups of 
patients with and without DW MRI lesions were 
descriptively compared in terms of MES counts 
using Wilcoxon’s rank-sum test. Logistic regres-
sion was used to evaluate the adjusted relationship 
between MES count and lesion development. Age 
was used as an apriori adjustment factor. Other 
potential explanatory variables were assessed for 
inclusion in the model. To improve distribution 
normality, age was cubic transformed, and the total 
MES count per MCA was natural log transformed. 
As curvature was observed in the relationship, 
a squared term for the log MES count was also 
used. Interactions were detected between the 
log MES count and age cubed, and between the 
squared log MES count and age cubed, and were 
therefore, included in the model. The effects of the 
MES count were expressed by comparing the odds 
for lesion development at a MES count of 1500 
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(a value close to the sample 75th percentile) to that 
at a count of 1100 (close to the sample median) in 
terms of odds ratios and 95% confidence intervals, 
specifically for levels across the range of age within 
which lesion development was observed. Model 
checking was based on the Hosmer–Lemeshow 
goodness of fit test.
Results
Patient and procedural characteristics
A total of 36 consecutive patients who un-
derwent PVI with the PVAC and the GENius 14.4 
generator gave consent to pre- and post-ablation 
cerebral MRI and to intra-procedural TCD moni-
toring. Two patients withdrew their consents 
from post-ablation MRI. TCD recording of MESs 
with sufficient quality could not be achieved in 7, 
thereby the full data sets of 27 patients were avail-
able for analysis (Table 1).
A total of 108 PVs were successfully isolated. 
The mean (SD) procedure and fluoroscopy times 
were 106 (27.1) min and 23 (10), respectively. Pro-
cedural complications included 1 case of pericar-
dial tamponade which required pericardiocentesis. 
Clinical stroke did not occur in any of the patients 
during or within 1 month after the ablation. 
TCD and MRI results
The median (IQR) MES count per patient was 
1151 (584). The highest rate of micro-embolization 
in any stage of the procedure was recorded during 
RF delivery (Fig. 1) and the majority of the MESs 
were gaseous during all phases of data collection 
(Fig. 2).
New SCI on DW MRI after PVI was demon-
strated in 6 (22%) patients: a single lesion in 2, two 
lesions in 3, and three lesions in 1 case (Table 2). 
The average (SD) lesion diameter was 7.05 (2.9) 
mm (4.1–13.4 mm). The majority of these lesions 
had disappeared by the 3-month follow-up: 1 pa-
tient had only a single lesion still detectable with 
a significant size reduction, and no new lesion as 
compared with the post-ablation image was dem-
onstrated in any patient.
Several clinical parameters were investigated 
as possible predictors for SCI, including age, gen-
der, LA diameter, left ventricular ejection fraction, 
CHA2DS2-VASC score, lacunary infarction on the 
preablation MRI, the total energy delivery time, the 
number of contrast injections during theprocedure, 
the percentage of concomitant use of E1/E10 and 
the mean intra-procedural ACT (Table 3). There 
was no significant difference among baseline clini-
cal parameters between patients with and without 
new SCI.
Association between micro-embolization 
and MRI lesions
Comparative analysis between TCD and MRI 
results are shown in Table 4. The total median 
Table 1. Baseline clinical and procedural para-
meters of the study population (n = 27). 
Parameter Median (IQR) or 
mean ± SD
Age [years] 64 (13.23)
Male/Female 21/6
LA diameter [mm] 41.88 ± 4.39
LVEF [%] 56.77 ± 3.61
CHADS2-Vasc:
0 2
1 10
≥ 2 15
Lacunary infarction present  
on pre-ablation MRI
16 (59.2%)
Total energy delivery time [s] 1001.63 ± 280.47
Number of contrast injections 5 ± 3
E1-E10 concomitantly active  
[% of the EDs]
34.2 ± 21.45
ACT [s] 341 (52) 
IQR — interquartile range; LA — left atrium; LVEF — left ventricular 
ejec-tion fraction; MRI — magnetic resonance imaging; ACT — acti-
vated clotting time; SD — standard deviation; EDs — energy  
deliveries
Figure 1. Total micro-embolic signal (MES) counts dur-
ing different stages of the procedure. Figure depicting 
the number of MESs recorded during different stages 
of the pulmonary vein (PV) isolation. The highest rate of 
micro-embolization in any stage of the procedure was 
recorded during radiofrequency delivery.
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MES count (IQR) during the procedures among 
the patients who demonstrated new acute MRI 
lesions was 1642.25 (912) as compared with 1019 
(529) recorded in those who had no new lesions, 
the difference did not reach the level of statistical 
significance at this patient cohort size (p = 0.129). 
However, the MES count per patient recorded 
during PV angiography was significantly higher in 
the patients with versus those without new brain 
lesions: 257 (249) vs. 110 (71), respectively (p = 
= 0.0009). Further, the multivariate logistic regres-
sion results demonstrated that the total MES count 
detected during the entire procedure was predic-
tive of silent cerebral lesions at an advanced age: 
patients aged 68 years or older were significantly 
more likely, in a progressive manner to acquire 
new brain lesions if the number of MESs was high 
(Table 5).
Discussion 
According to available research, this is the 
first study that has assessed the relationship 
between post-ablation SCI on DW MRI and the 
number of micro-emboli detected by TCD during 
PVI. A higher total MES count recorded during 
Figure 2. Ratio of solid versus gaseous emboli during different stages of the procedure. Figure illustrating the 
percentage of solid and gaseous micro-emboli detected during pulmonary vein (PV) isolation. The majority of the 
micro-embolic signal (MES) were gaseous during all phases of data collection.
Table 2. Magnetic resonance imaging (MRI) lesion characteristics after pulmonary vein isolation.
Patient No. of  
lesions
Lesion size  
[mm]
Presence  
on DWI
Presence  
on FLAIR
Persistent lesion on  
3-month control MRI
1 2 8.5 Yes Yes No
9.5 Yes Yes No
2 1 4.6 Yes Yes No
3 3 4.4 Yes No No
4.9 Yes No No
6.6 Yes No No
4 2 4.7 Yes No No
8.6 Yes Yes No
5 2 8.3 Yes Yes Yes
4.1 Yes No No
6 1 13.4 Yes Yes No
DWI — diffusion-weighted image sequence; FLAIR — fluid-attenuated inversion recovery sequence
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the overall LA access time in patients with a new 
lesion on DW MRI (median: 1642 vs. 1019) was 
demonstrated, though the difference did not reach 
the level of statistical significance as there were 
a limited number of patients with positive MRI 
findings. Nonetheless, the relationship between 
the total MES count and SCI among the older 
patients was significant, suggesting that not only 
a micro-embolic load to the brain, but also the sta-
tus of the cerebral vasculature might be relevant 
in lesion formation. Reduction of micro-embolus 
generation to the lowest possible level therefore 
seems especially important in the elderly, and it 
should be considered when selecting the ablation 
technique in this patient cohort. Further, additional 
risk of SCI has to be considered in these patients.
The MES count recorded during PV angiog-
raphy proved to be a significant predictor of new 
cerebral lesions in this study. As the number of 
Table 3. Clinical and procedural parameters in patients with or without new silent ischemic lesions.
Patients with  
DW MRI lesions (n = 6)
Patients without  
DW MRI lesions (n = 21)
P
Age [years]; median (IQR) 63.7 (12.3) 65.5 (7.1) 0.22
Male/Female 5/1 16/5 0.596
LA diameter [mm]; median (IQR) 41 (4) 42 (6) 0.452
LVEF [%]; median (IQR) 55 (4) 57 (5) 0.2
CHA2DS2-Vasc; median (IQR) 2 (1) 2 (2) 0.513
Lacunary infarction present  
on pre-ablation MRI
4 (66.67%) 13 (61.9%) 0.613
Total energy delivery time [s]; median (IQR) 1045.3 (263) 978 (382) 0.64
Number of contrast injections; median (IQR) 5.5 (5) 4 (1) 0.179
E1-E10 concomitantly active (% of the EDs); 
median (IQR)
21 (10) 36 (30) 0.121
ACT [s]; median (IQR) 351.2 (58) 341 (50) 0.43
IQR — interquartile range; DW MRI — diffusion-weighted magnetic resonance imaging; ACT — activated clotting time; LA — left atrium;  
LVEF — left ventricular ejection fraction; EDs — energy deliveries
Table 4. Transcranial Doppler results in patients with or without new lesions on post-ablation DW MRI. 
MES count during different stages  
of the procedure
Patients with  
DW MRI lesions  
(n = 6)
Patients without  
DW MRI lesions  
(n = 21)
P
Total MES/MCA during transseptal puncture; median (IQR) 11.5 (11.5) 4.75 (7) 0.759
Total MES/MCA during PV angiography; median (IQR) 257 (249) 110 (71) 0.0009
Total MES/MCA during energy delivery; median (IQR) 559 (679.5) 560.5 (450.5) 0.521
Total MES/MCA during catheter manipulation; median (IQR) 541.25 (573) 382 (251) 0.35
Total MES/MCA during the whole procedure; median (IQR) 1642.25 (912) 1019 (529) 0.129
DW MRI — diffusion-weighted magnetic resonance imaging; MES — micro-embolic signal; MCA — middle cerebral artery;  
IQR — interquartile range; PV — pulmonary vein
Table 5. Logistic regression effect estimates for 
a contrast of 1500 vs. 1100 in total micro-embolic 
signal count on the odds of magnetic resonance 
imaging lesion development across the observed 
range of age levels.
Age OR 95% CI P
54 0.15 0.02–1.35 0.0904
56 0.22 0.03–1.46 0.1175
58 0.34 0.07–1.62 0.1779
60 0.55 0.16–1.90 0.3465
62 0.92 0.34–2.47 0.8677
64 1.58 0.62–4.03 0.3389
66 2.81 0.90–8.79 0.0759
68 5.18 1.12–24.04 0.0356
70 9.92 1.29–76.05 0.0273
72 19.72 1.45–268.13 0.0251
OR — odds ratio; CI — confidence interval
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micro-emboli recorded during PV angiography 
comprises only a relatively small fraction of the 
total MES count recorded throughout the entire 
procedure, the strong correlation with SCI was 
somewhat unexpected. Although the majority are 
gaseous, similarly to those recorded during other 
phases of the procedure, the physical characteris-
tics of MESs generated during contrast injections 
may differ. Moreover, PV angiography involves the 
injection of rapid boluses of contrast material into 
systemic circulation, and micro-emboli, although 
relatively small in number, are thereby, introduced 
within a very short time. It may be speculated that, 
besides the number of micro-emboli, the intensity 
of these micro-embolic showers reaching the brain 
circulation might also be an important determinant 
of lesion formation.
The present results are in line with recent 
data published from the Mayo Clinic. In an elegant 
in vivo pig model Takami et al. [16] performed 
different catheter, sheath manipulations and abla-
tions while measuring micro-embolization using 
intracardiac echocardiography, Carotid Doppler, and 
an extra-corporal circulation loop which included 
a microbubble counter and blood filters to collect 
particulas. Significant microbubble formation was 
demonstrated on ICE, Carotid Doppler and in the 
loop during PV angiography and sheath flushing 
at a high flow, while micro-particles were mostly 
found during catheter dragging and after a steam 
pop. The present findings in patients appear to 
support these experimental data and may well 
have important practical implications as around half 
of the ablation centers worldwide [17] routinely 
perform PV angiography during PVI.
Importantly, the definition presented here 
of SCI was any new finding concerning the DW 
sequence with or without FLAIR positivity. This 
is different from the definitions used in most 
other studies [1, 2, 6, 7]. This more sensitive 
criterion was chosen  to enable consideration 
of any detectable brain ischemia for comparison 
with MES data. FLAIR positivity was found in 
5 of 6 patients and in 6 of 11 lesions in our study, 
and the majority of the lesions had resolved by 
the 3-month follow-up. 
Although the aim of this research was to as-
sess the relationship between TCD and DW MRI 
findings and not to evaluate the safety of phased RF 
ablation, it is noteworthy that lower incidences of 
SCI have been found in recent multi-center studies 
[18, 19]. This favorable trend has been attributed 
to procedural modifications of phased RF ablation 
based on the results of clinical and preclinical stud-
ies [20, 21]. RF delivery to electrodes 1 and 10 
getting close to each other due to a wedge position 
of the PVAC loop has been identified as the most 
significant contributor to embolus generation due 
to high current density, therefore simultaneous 
energization of these electrodes was prohibited 
in these trials and electrode 10 was even being 
removed from the novel PVAC Gold. Concomitant 
RF application on poles 1 and 10 was however not 
a priori excluded in the present study, and only 
when the inter-electrode distance on fluoroscopy 
was considered unsafe. Nonetheless, this more 
“liberal” practice did not contribute to a higher 
incidence of SCI lesions in this study.
The importance of SCI after AF ablation 
remains unclear. The concern that these lesions 
might be related to cognitive decline is supported 
by limited data [22, 23]. It has also been suggested 
that these lesions might be viewed as surrogates 
for the clinical stroke risk and are useful for an 
assessment of the risk involved with different 
ablation techniques and procedural changes [24]. 
The present data does suggest that TCD detection 
during LA ablation might improve our understand-
ing of the micro-embolization process during these 
procedures. 
Limitations of the study
The most important limitation of this study is 
the relatively small number of patients, and espe-
cially the low number of those with a new lesion 
on DW MRI after ablation. This exemplifies the 
challenges of enrolling patients that require non-
standard of care MRIs and the technical difficul-
ties of TCD examination during relatively longer 
procedures in some patients. Although these 
observations reduced the power of the statistical 
analysis, a strong relationship between SCI and the 
MES count recorded during PV angiography was 
still demonstrated. Importantly, PVI was performed 
using phased RF exclusively in this study. Future 
studies with similar design but with different abla-
tion technologies (cryoballoon, focal irrigated RF) 
might therefore be of interest.
Conclusions
This study demonstrates a relationship between 
micro-embolization detected by TCD over the MCA 
and acute SCI on DW MRI after PVI with phased 
radiofrequency and the pulmonary vein ablation 
catheter. Higher numbers of micro-emboli detected 
during pulmonary vein angiography were predictive 
of positive postablation findings on DW MRI.
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